NFKB1 and cancer: The efficacy of DS extends to a variety of cancers and, in addition to induction of apoptosis, DS also acts by proteasome inhibition, generation of reactive oxygen species (O2−) and attenuation of NF-KB activities (Chen et al., 2002; Ketola et al., 2012; Robinson et al., 2013).